MRC1 and neoplasm: An alternative explanation is that there are other molecular mechanisms that inactivate MMR in addition to canonical inactivation via a gene mutation; indeed, MMR activity may also be modulated by changes in MMR gene expression, causing the same tumor phenotype that closely resembles Lynch syndrome [81].